Faculty/Research
Berman, Doreen, Ph.D.
Bodnar, Richard J., Ph.D.
Borod, Joan C., Ph.D.
Bruder, Gerard, Ph.D.
Brumbaugh, Claudia, Ph.D.
Brumberg, Joshua, Ph.D.
Chacko, Anil, Ph.D.
Croll, Susan D., Ph.D.
Ehrlichman, Howard, Ph.D.
Farrell, William, Ph.D.
Fields, Lanny, Ph.D.
Flory, Janine, Ph.D.
Foldi, Nancy, Ph.D.
Foxe, John, Ph.D.
Golub, Sarit, Ph.D.
Gomes, Hilary, Ph.D.
Halperin, Jeffrey, Ph.D.
Hinton, Veronica, Ph.D.
Johnson, Ray, Jr., Ph.D.
Kest, Benjamin, Ph.D.
Kluger, Alan, Ph.D.
Li, Andrea, Ph.D.
Lizardi, Humberto, Ph.D.
Pytte, Carolyn L., Ph.D.
Rabin, Laura, Ph.D.
Ranaldi, Robert, Ph.D.
Ravdin, Lisa, Ph.D.
Sclafani, Anthony, Ph.D.
Sneed, Joel, Ph.D.
Sturmey, Peter, Ph.D.
Walder, Deborah, Ph.D.
Kluger, Alan, Ph.D.
Professor
Education: Ph.D. City University of New York (Neuropsychology)
Email: alan.kluger@lehman.cuny.edu
Office: Lehman College, Gillet Hall, 113 / 125
Telephone: 718.960.8204
Lab: Lehman College, Gillet Hall, 025
Selected Publications:
Kluger, A., Gianutsos, J.G., Golomb, J., Wagner, A., Wagner, D. & Scheurich, S. (2008). Clinical changes in MCI: Motor/psychomotor changes. International Psychogeriatrics, 20 (1), 32-39.
Kluger, A. & Golomb, J. (2008). Neuropsychological assessment & Neuropsychologists. In E. Capezuti, E.L. Siegler, and M. Mezzy (Eds.), The Encyclopedia of Elder Care (2nd Ed.). New York: Springer Co., 551-557.
Reisberg, B. Ferris, S.H., Kluger, A., Franssen, E., Wegiel, J., & de Leon, M.J. (2008). Mild Cognitive Impairment (MCI): A Historical Approach International Psychogeriatrics, International Psychogeriatrics, 20 (1), 18-31.
Golomb, J., Kluger, A., & Ferris, S.H., (2004). Mild Cognitive Impairment: historical development and summary of research. Dialogues in Clinical Neuroscience, 6, 351-367.
Salloway, S.P., Ferris, S., Kluger, A., Goldman, R., Griesing, T., Kumar,D., & Richardson, S. (2004). Efficacy of donepezil in mild cognitive impairment: A randomized placebo-controlled trial. Neurology, 63, 651-657.
Research Summary:
My main areas of research are cognitive and motor impairment in normal aging, mild cognitive impairment (MCI), Alzheimer’s disease (AD) and associated dementias such as normal pressure hydrocephalus (NPH). A particular focus has been in the early detection of Alzheimer’s disease among non-demented elderly. In this regard, I have been a long-time collaborator of a clinical research group at NYU School of Medicine’s Silberstein Aging and Dementia Research Center, a team that has been instrumental in characterizing MCI. MCI is a condition in between normal aging and mild dementia; individuals with MCI are heightened risk for future decline to AD, compared to cognitively normal elderly.
Doctoral Students:
Elizabeth Guerrero-Berroa
Jamie Park